<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
    <channel>
      <title>Dengue Literature Review</title>
      <link>https://dengue-wiki-web.pages.dev</link>
      <description>Last 10 notes on Dengue Literature Review</description>
      <generator>Quartz -- quartz.jzhao.xyz</generator>
      <item>
    <title>commands</title>
    <link>https://dengue-wiki-web.pages.dev/commands</link>
    <guid>https://dengue-wiki-web.pages.dev/commands</guid>
    <description><![CDATA[ Wiki Commands Reference All commands used to operate, maintain, and serve the Dengue Literature Review Wiki. ]]></description>
    <pubDate>Tue, 14 Apr 2026 19:23:24 GMT</pubDate>
  </item><item>
    <title>index</title>
    <link>https://dengue-wiki-web.pages.dev/</link>
    <guid>https://dengue-wiki-web.pages.dev/</guid>
    <description><![CDATA[ Dengue Wiki — Master Index Last updated: 2026-04-14 | Sources: 20 | Total pages: 75 Sources (20) PageYearJournalCitations (SS / CR)Key TopicsGarcia2009 - Long-term Clinical Symptoms Post-Dengue2009Int J Infect Dis133 / 110Post-dengue syndrome, FcγRIIa polymorphism, autoimmunity, Cuba DENV-4Garcia201... ]]></description>
    <pubDate>Tue, 14 Apr 2026 19:23:24 GMT</pubDate>
  </item><item>
    <title>log</title>
    <link>https://dengue-wiki-web.pages.dev/log</link>
    <guid>https://dengue-wiki-web.pages.dev/log</guid>
    <description><![CDATA[ Wiki Operation Log [2026-04-14] lint | health check Errors fixed: wiki/index.md — section header Sources (19) corrected to Sources (20); Geography (5) corrected to Geography (6); Autoimmunity in Dengue | 15 corrected to 16; Secondary Dengue Infection | 5 corrected to 6; IgM-IgG Serology ELISA | 2 co... ]]></description>
    <pubDate>Tue, 14 Apr 2026 19:23:24 GMT</pubDate>
  </item><item>
    <title>Notable Findings</title>
    <link>https://dengue-wiki-web.pages.dev/analyses/Notable-Findings</link>
    <guid>https://dengue-wiki-web.pages.dev/analyses/Notable-Findings</guid>
    <description><![CDATA[ Notable Findings A running log of observations that are striking, unexpected, or carry implications beyond the paper they came from. ]]></description>
    <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
  </item><item>
    <title>Antibody-Dependent Enhancement</title>
    <link>https://dengue-wiki-web.pages.dev/concepts/Antibody-Dependent-Enhancement</link>
    <guid>https://dengue-wiki-web.pages.dev/concepts/Antibody-Dependent-Enhancement</guid>
    <description><![CDATA[ Antibody-Dependent Enhancement Overview Antibody-dependent enhancement (ADE) is a mechanism by which cross-reactive, non-neutralising antibodies from a prior dengue infection bind a new infecting serotype and enhance viral uptake into Fc receptor-bearing cells (monocytes, macrophages, dendritic cell... ]]></description>
    <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
  </item><item>
    <title>Autoimmunity in Dengue</title>
    <link>https://dengue-wiki-web.pages.dev/concepts/Autoimmunity-in-Dengue</link>
    <guid>https://dengue-wiki-web.pages.dev/concepts/Autoimmunity-in-Dengue</guid>
    <description><![CDATA[ Autoimmunity in Dengue Overview Dengue virus infection can trigger transient or prolonged autoimmune responses. ]]></description>
    <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
  </item><item>
    <title>Cross-Reactive Antibodies</title>
    <link>https://dengue-wiki-web.pages.dev/concepts/Cross-Reactive-Antibodies</link>
    <guid>https://dengue-wiki-web.pages.dev/concepts/Cross-Reactive-Antibodies</guid>
    <description><![CDATA[ Cross-Reactive Antibodies Overview Cross-reactive antibodies are immunoglobulins generated against one dengue serotype (or another flavivirus) that bind — but do not necessarily neutralise — a different serotype. ]]></description>
    <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
  </item><item>
    <title>Secondary Dengue Infection</title>
    <link>https://dengue-wiki-web.pages.dev/concepts/Secondary-Dengue-Infection</link>
    <guid>https://dengue-wiki-web.pages.dev/concepts/Secondary-Dengue-Infection</guid>
    <description><![CDATA[ Secondary Dengue Infection Overview Secondary dengue infection refers to infection with a DENV serotype different from a prior primary infection. ]]></description>
    <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
  </item><item>
    <title>E Protein</title>
    <link>https://dengue-wiki-web.pages.dev/entities/E-Protein</link>
    <guid>https://dengue-wiki-web.pages.dev/entities/E-Protein</guid>
    <description><![CDATA[ E Protein Overview The envelope (E) protein is the major surface structural protein of dengue virions and the primary target of neutralising antibodies. ]]></description>
    <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
  </item><item>
    <title>NS1 Protein</title>
    <link>https://dengue-wiki-web.pages.dev/entities/NS1-Protein</link>
    <guid>https://dengue-wiki-web.pages.dev/entities/NS1-Protein</guid>
    <description><![CDATA[ NS1 Protein Overview NS1 (Non-Structural Protein 1) is a ~48 kDa glycoprotein encoded by the dengue virus genome. ]]></description>
    <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
  </item>
    </channel>
  </rss>